| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
8,983,226 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,100 |
4,860 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2021-12-14 |
4 |
D |
$168.43 |
$566,935 |
D/D |
(3,366) |
27,480 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2021-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,967 |
30,846 |
|
- |
|
| Trizzino John |
EVP, CCO and CBO |
• – – |
2021-12-14 |
4 |
D |
$168.43 |
$130,196 |
D/D |
(773) |
3,373 |
|
- |
|
| Trizzino John |
EVP, CCO and CBO |
• – – |
2021-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,600 |
4,146 |
|
- |
|
| Douglas Richard |
Director |
– • – |
2021-12-13 |
4 |
OE |
$25.60 |
$38,400 |
D/D |
1,500 |
33,450 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-12-07 |
4 |
AS |
$150.30 |
$1,403,631 |
D/D |
(8,250) |
4,061 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-12-07 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-12-01 |
4 |
AS |
$192.64 |
$980,944 |
D/D |
(5,000) |
2,760 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-12-01 |
4 |
OE |
$19.08 |
$95,400 |
D/D |
5,000 |
7,760 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-26 |
4 |
D |
$217.97 |
$141,027 |
D/D |
(647) |
4,753 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-26 |
4 |
D |
$217.97 |
$8,283 |
D/D |
(38) |
5,400 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-26 |
4 |
OE |
$5.95 |
$20,587 |
D/D |
3,460 |
5,438 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-26 |
4 |
AS |
$215.00 |
$454,247 |
D/D |
(2,083) |
4,061 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-16 |
4 |
AS |
$166.89 |
$1,398,180 |
D/D |
(8,250) |
4,061 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-16 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-15 |
4 |
AS |
$172.02 |
$203,496 |
D/D |
(1,183) |
4,061 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-15 |
4 |
OE |
$27.60 |
$44,832 |
D/D |
1,183 |
5,244 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-09 |
4 |
AS |
$164.23 |
$1,382,160 |
D/D |
(8,250) |
4,061 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-09 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-11-03 |
4 |
AS |
$200.00 |
$1,000,000 |
D/D |
(5,000) |
2,760 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-11-03 |
4 |
OE |
$19.08 |
$95,400 |
D/D |
5,000 |
7,760 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-02 |
4 |
AS |
$177.12 |
$1,516,552 |
D/D |
(8,250) |
4,061 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-11-02 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-11-01 |
4 |
AS |
$155.16 |
$815,422 |
D/D |
(5,000) |
2,760 |
|
- |
|
602 Records found
|
|
Page 5 of 25 |
|
|
